Jazz Pharmaceuticals
JAZZ
JAZZ
323 hedge funds and large institutions have $7.32B invested in Jazz Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 101 increasing their positions, 105 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 105
9% less capital invested
Capital invested by funds: $8.03B → $7.32B (-$710M)
68% less call options, than puts
Call options by funds: $16.5M | Put options by funds: $51.9M
Holders
323
Holding in Top 10
6
Calls
$16.5M
Puts
$51.9M
Top Buyers
| 1 | +$161M | |
| 2 | +$36.9M | |
| 3 | +$35.7M | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$23.7M |
| 5 |
Goldman Sachs
New York
|
+$23M |
Top Sellers
| 1 | -$156M | |
| 2 | -$74M | |
| 3 | -$52.8M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$39.9M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$32.6M |